Press Release: United Imaging Healthcare Announces Q3 2024 Results with Revenue of January to September of 6.95 Billion CNY

Dow Jones
2024-11-04

United Imaging Healthcare Announces Q3 2024 Results with Revenue of January to September of 6.95 Billion CNY

PR Newswire

SHANGHAI, Nov. 4, 2024

SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE: 688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, announced its financial results for the third quarter of 2024. Reflecting its development strategy and strategic R&D investments, the company reported that revenue of January to September is 6.95 billion CNY, with net income attributable to shareholders reaching 0.67 billion CNY.

In 2024, United Imaging Healthcare has significantly increased its R&D efforts to pioneer high-end medical technologies and support the digital transformation of healthcare institutions. To date, over ten innovative United Imaging Healthcare products have received market approval,* including:

   -- uLinac HalosTx, an integrated CT circular linear accelerator 
 
   -- uMI Panvivo, a robust new PET/CT platform 
 
   -- uMI Panorama GS, a next-generation, 148cm whole-body PET/CT system 
 
   -- uOmnispace, a hospital-grade intelligent post-processing software suite 

These innovations, with the uMI Panorama molecular imaging solution as a key highlight, have gained international recognition. uMI Panorama has been installed at premier institutions in the United States. And, at the EANM 2024 the European Association of Nuclear Medicine (EANM) annual congress, United Imaging Healthcare launched its next-generation PET/CT system, the uMI Panvivo, which will be unveiled for U.S. audiences at the Radiologic Society of North America annual meeting in Chicago, as part of an innovation launch featuring multiple new products in several modalities.

Committed to advancing medical innovation through exceptional R&D capabilities and industry leadership, United Imaging Healthcare was recently honored on the Fortune China Tech 50 for 2024. This prestigious recognition underscores United Imaging Healthcare's role in pioneering healthcare technology and elevating standards in medical imaging and patient care globally.

*not all products noted are clinically or commercially available in the U.S.

About United Imaging Healthcare

At United Imaging Healthcare, we develop and produce advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment. Founded in 2011, our company has subsidiaries and R&D centers across China, the United States, Poland, Dubai, and other parts of the world. With a cutting-edge digital portfolio and a mission of Equal Healthcare for All$(TM)$, we help drive industry progress and bold change. To learn more, visit https://www.united-imaging.com

View original content:https://www.prnewswire.com/news-releases/united-imaging-healthcare-announces-q3-2024-results-with-revenue-of-january-to-september-of-6-95-billion-cny-302295094.html

SOURCE United Imaging Healthcare Co., Ltd.

/CONTACT: Xinyu Du, xinyu.du@united-imaging.com

 

(END) Dow Jones Newswires

November 04, 2024 01:29 ET (06:29 GMT)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10